DegenRx B.V.

Private

TilburgHealthcare & Life Sciences

Last Round

Grant

Jun 4, 2019

Company Overview

DegenRx B.V. is a biotechnology company developing AAV-mediated gene therapy for the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyAAVadeno-associated-viral vectorsneurodegenerative diseaseblood-brain barriertherapeutic antibodiesbiotech startupCNS diseasesdrug discoverybiologicspre-clinical researchgenetic medicinebrain deliveryvector biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DegenRx B.V. Comps

Public and private peers based on sector, stage, and business model.

DegenRx B.V. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DegenRx B.V. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jun 4, 2019
Series A	Dec 21, 2018

View all Funding Rounds

DegenRx B.V. Investors

Notable investors and investment history

DegenRx B.V. investors
Investor	Rounds
Swanbridge Capital	Series A
BOM Brabant Ventures	Series A
Health~Holland	Grant

View all Investors

DegenRx B.V. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

DegenRx B.V. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DegenRx B.V.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTilburg

Year Founded2018

Last FundingJun 4, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.